Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)

NCT02612077 · clinicaltrials.gov ↗

COMPLETED

Status

765

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

OTHER: Observational Chemotherapy
DRUG: Concomitant Bevacizumab

Sponsor

Hoffmann-La Roche